explore -WSS

explore

author：focus 2025-09-29 22:50:26 - browse：1

Multiple syringes in a vial -- Pharma coverage from STAT — Adobe

Roughly two million Americans are expected to receive a cancer diagnosis this year. Some members of this already vulnerable group will wind up facing what physician Andrew Schuman recently called “a tragedy happening in slow motion” — an ongoing, nationwide shortage of critical oncology drugs that routinely save or extend the lives of children and adults.

Speaking at a March 22 Senate hearing on drug shortages, Schuman, a head and neck surgeon at the U.S. Department of Veterans Affairs, described the agonizing decisions that doctors must make when critical medicines are in short supply. “Should our limited vials go to an older woman who was just diagnosed with lung cancer? To a young man who had already been successfully taking it for his testicular cancer? Or a baby with neuroblastoma?” he asked. “As a doctor who has devoted my life to fighting cancer, it is hard to express how horrible it is to face this kind of tragedy.”

The dilemmas caused by cancer drug shortages are unfortunately nothing new. In the past decade alone, eight of the 10 drugs most commonly used to treat acute lymphoblastic leukemia, the most common kind of childhood cancer type of leukemia, have been temporarily unavailable. The problem has been getting worse: Nationwide shortages of critical drugs increased nearly 30% in 2022, soaring to their highest level in nearly five years, according to a report released by the Senate Homeland Security and Governmental Affairs Committee for the hearing. Oncology drugs currently in short supply include methotrexate, which treats breast and soft tissue cancers; cisplatin, which treats testicular, ovarian, bladder, head and neck, lung, and cervical cancers; fluorouracil, which treats skin cancer; Pluvicto, for prostate cancer; and the injectable bacillus Calmette-Guérin, for bladder cancer.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Ripples from Flovent's discontinuation is killing children with asthma

hotspot

WSS

Free medical tuition alone isn't enough to close gaps in primary care

Novo Nordisk testing Wegovy against alcohol

2 US Navy sailors arrested for allegedly spying for China

Free medical tuition alone isn't enough to close gaps in primary care

Attacks on the drug industry will lead to fewer breakthroughs

Supreme Court to hear if Covid misinformation is protected speech

knowledge

explore

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

ProMED, early warning system on disease outbreaks, in peril

Moonlake's readout produced a cash windfall. Risks remain

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

Alkermes shareholders re

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Nearly two

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

'Ancient DNA,' 23andMe reveal African American ancestries

leisure time

The drug industry sees a key ally in the Senate prevail

Oak Street deal isn't the answer to health care's woes

2 US Navy sailors arrested for allegedly spying for China

ProMED, early warning system on disease outbreaks, in peril

A cyberattack has disrupted hospitals and health care in several states

Stem cell clinics for heart failure: buyer be wary

hotspot

focus

hotspot

Wikipedia